New Insights on Long-Term Aspirin Therapy in Primary Prevention for Cardiovascular Disease

The atherosclerosis-related cardiovascular diseases, such as coronary artery disease, stroke and peripheral artery disease, are the leading cause of death and morbidity in the United States and Europe. The pathophysiology of atherosclerotic plaque is essential to understand the criticality of these diseases and the correct functioning of pharmacological strategies. The use of statins, both primary and secondary prevention, it is well established in clinical practice based on scientific evidence; however, the use of aspirin in primary prevention is widely debated.


Gabriele Cioni

Abstract | Full-Text | PDF

Share this  Facebook  Twitter  LinkedIn  Google+

Recommended Conferences

  • Cardiovascular Medicine and Cardiac Surgery
    July 05-06, 2018 Berlin, Germany
  • International Conference on Cardiovascula r Imaging
    July 11-12, 2018 Sydney,Australia
Flyer image

Abstracted/Indexed in

  • Index Copernicus
  • Google Scholar
  • Directory of Research Journal Indexing (DRJI)
  • WorldCat